Publications - 'D'
Publications 26 - 50 de 1753
| Titre | DOI |
|---|---|
|
Daily update of motor predictions by physical activity N. Gueugneau; N. Schweighofer; C. Papaxanthis 2015 |
10.1038/srep17933 |
|
Daily use of extracorporeal CO2 removal in a critical care unit: indications and results H. Winiszewski; F. Aptel; F. Belon; N. Belin; C. Chaignat; C. Patry; C. Clermont; E. David; J.C. Navellou; G. Labro; G. Piton; G. Capellier 2018 |
10.1186/s40560-018-0304-x |
|
Daily Versus Weekly Prostate Cancer Image Guided Radiation Therapy: Phase 3 Multicenter Randomized Trial R. de Crevoisier; M.Amine Bayar; P. Pommier; X. Muracciole; F. Pene; P. Dudouet; I. Latorzeff; V. Beckendorf; J.M. Bachaud; A. Laplanche; S. Supiot; B. Chauvet; T.D. Nguyen; A. Bossi; G. Crehange; J.Leon Lagrange 2018 |
10.1016/j.ijrobp.2018.07.2006 |
|
Daily versus weekly prostate cancer image-guided radiotherapy: A Phase 3 randomized trial R. de Crevoisier; M. Bayar; P. Pommier; X. Muracciole; F. Pene; P. Dudouet; I. Latorzeff; V. Beckendorf; J. Bachaud; S. Supiot; B. Chauvet; A. Laplanche; A. Bossi; T. Nguyen; G. Crehange; J. Lagrange 2018 |
10.1016/S0167-8140(18)30848-X |
|
Daily versus weekly prostate cancer image-guided radiotherapy: A phase 3, multicenter, randomized trial. R. de Crevoisier; M.A. Bayar; P. Pommier; X. Muracciole; F. Pene; P. Dudouet; I. Latorzeff; V. Beckendorf; J.M. Bachaud; A. Laplanche; S. Supiot; B. Chauvet; T.D. N'Guyen; A. Bossi; G. Crehange; J.L. Lagrange 2018 |
10.1200/JCO.2018.36.6_suppl.4 |
|
Daily Weather Types in February-June (1979-2016) and Temperature Variations in Tropical North Africa V. Moron; B. Oueslati; B. Pohl; S. Janicot 2018 |
10.1175/JAMC-D-17-0105.1 |
|
Dalfampridine in hereditary spastic paraplegia: a prospective, open study M. Bereau; M. Anheim; J.B. Chanson; G. Tio; A. Echaniz-Laguna; C. Depienne; N. Collongues; J. de Seze 2015 |
10.1007/s00415-015-7707-6 |
|
Damage detection of a hybrid composite laminate aluminum/glass under quasi-static and fatigue loadings by acoustic emission technique A. Dia; L. Dieng; L. Gaillet; P.Birame Gning 2019 |
10.1016/j.heliyon.2019.e01414 |
|
Damage in composite material: A Microwave detection J. Rossignol; A. Thionnet 2014 |
10.4028/www.scientific.net/KEM.605.303 |
|
Damped inertial dynamics with vanishing Tikhonov regularization: Strong asymptotic convergence towards the minimum norm solution H. Attouch; A. Balhag; Z. Chbani; H. Riahi 2022 |
10.1016/j.jde.2021.12.005 |
|
Damping behavior of plant fiber composites: A review T. Liu; P. Butaud; V. Placet; M. Ouisse 2021 |
10.1016/j.compstruct.2021.114392 |
|
Damping control for improvement of acoustic black hole effect M. Ouisse; D. Renault; P. Butaud; E. Sadoulet-Reboul 2019 |
10.1016/j.jsv.2019.04.029 |
|
DAMPING CONTROL IN A SANDWICH STRUCTURE WITH SMP CORE P. Butaud; M. Ouisse; E. Foltete 2016 |
|
|
Danger signals: Chemotherapy enhancers? T.Rivera Vargas; L. Apetoh 2017 |
10.1111/imr.12581 |
|
Daniel Russo: Counting for Seeing; Seeing for Counting. The Painted Decorations in the Germolles Chateau from the Period of Philip the Bold and of Margaret of Flanders (end of the 14th century) D. Russo 2019 |
|
|
Daniel Russo: Counting for Seeing; Seeing for Counting. The Painted Decorations in the Germolles Chateau from the Period of Philip the Bold and of Margaret of Flanders (end of the 14th century) D. Russo 2019 |
|
|
Daptomycin-induced eosinophilic pneumonia: Are there any risk factors? N. Ahouansou; M. Georges; G. Beltramo; N. Aswad; Y. Hassani; P. Bonniaud 2021 |
10.1016/j.idnow.2021.01.002 |
|
Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial E.M. Boyle; X. Leleu; M.O. Petillon; L. Karlin; C. Doyen; H. Demarquette; B. Royer; M. Macro; P. Moreau; K. Fostier; C. Marie-Lorraine; C. Zarnitsky; A. Perrot; C. Herbaux; S. Poulain; S. Manier; D. Beauvais; B.A. Walker; C.P. Wardell; L. Vincent; L. Frenzel; H. Caillon; S. Susanna; T. Dejoie; H. Avet-Loiseau; M. Mohty; T. Facon; B. Arnulf; M. Dib; S. Brechignac-Bureau; P. Godmer; A. Tempescul; C. Fohrer; L. Benboubker; L. Voillat; J.Valere Malfuson; C. Mariette; M. Tiab; S. Rigaudeau; A. Jaccard; A.M. Stoppa; J.C. Eisenmann; P. Rodon; B. Kolb; O. Decaux; B. Onraed; M. Attal; C. Hulin; I.F.M.201404 Investigators 2019 |
10.1111/bjh.16059 |
|
Daratumumab displays in vitro and in vivo anti-tumor activity in models of B-cell non-Hodgkin lymphoma and improves responses to standard chemo-immunotherapy regimens A. Vidal-Crespo; A. Matas-Cespedes; V. Rodriguez; C. Rossi; J.G. Valero; N. Serrat; A. Sanjuan-Pla; P. Menendez; G. Roue; A. Lopez-Guillermo; E. Gine; E. Campo; D. Colomer; C. Bezombes; J.Lammerts van Bueren; C. Chiu; P. Doshi; P. Perez-Galan 2020 |
10.3324/haematol.2018.211904 |
|
Daratumumab in Combination with Dexamethasone in Resistant or Refractory Multiple Myeloma: Primary Results of the IFM2014-04 Trial E.Mary Boyle; M.O. Petillon; C. Herbaux; J. Mimouni; X. Leleu; L. Karlin; C. Doyen; M. Wetterwald; M. Roussel; C. Hulin; B. Royer; M. Macro; P. Moreau; K. Fostier; M. Dib; S. Brechignac; C. Bureau; G. Marit; A. Tempescul; M.Lorraine Chretien; C. Zarnitsky; C. Fohrer; A. Perrot; L. Benboubker; L. Voillat; J.Valere Malfuson; C. Mariette; M. Tiab; S. Rigaudeau; A. Jaccard; A.M. Stoppa; L. Vincent; J.Claude Eisenmann; L. Frenzel; B. Arnulf; M. Mohty; P. Rodon; B. Kolb; O. Decaux; P. Godmer; D. Beauvais; B. Carpentier; S. Bonnet; T. Longval; M. Dewevre; H. Avet-Loiseau; M. Attal; S. Schraen; T. Facon 2016 |
10.1182/blood.V128.22.2138.2138 |
|
Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTd) in Transplant-eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-risk Patients (Pts) in CASSIOPEIA P. Sonneveld; M. Attal; A. Perrot; C. Hulin; D. Caillot; T. Facon; X. Leleu; K. Belhadj-Merzoug; L. Karlin; L. Benboubker; M.D. Levin; M. Minnema; M. Westerman; M. Delforge; S. Zweegman; L. Pei; C. de Boer; V. Vanquickelberghe; T. Kampfenkel; P. Moreau 2019 |
10.1016/j.clml.2019.09.004 |
|
Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTD) in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-Risk Patients in Cassiopeia P. Sonneveld; M. Attal; A. Perrot; C. Hulin; D. Caillot; T. Facon; X. Leleu; K. Belhadj; L. Karlin; L. Benboubker; M.D. Levin; M.C. Minnema; M. Westerman; M. Delforge; S. Zweegman; L. Pei; C. de Boer; V. Vanquickelberghe; T. Kampfenkel; P. Moreau 2020 |
|
|
Daratumumab Plus Bortezomib, Thalidomide, and Dexamethasone (D-VTD) in Transplant-Eligible Newly Diagnosed Multiple Myeloma (NDMM): Subgroup Analysis of High-Risk Patients in Cassiopeia P. Sonneveld; M. Attal; A. Perrot; C. Hulin; D. Caillot; T. Facon; X. Leleu; K. Belhadj; L. Karlin; L. Benboubker; M.D. Levin; M.C. Minnema; M. Westerman; M. Delforge; S. Zweegman; L. Pei; C. de Boer; V. Vanquickelberghe; T. Kampfenkel; P. Moreau 2020 |
|
|
Daratumumab plus bortezomib, thalidomide, and dexamethasone (D-VTd) in transplant-eligible newly diagnosed multiple myeloma (TE NDMM): Baseline SLiM-CRAB based subgroup analysis of CASSIOPEIA. C. Touzeau; P. Moreau; A. Perrot; C. Hulin; M. Dib; M. Tiab; D. Caillot; T. Facon; X. Leleu; N.W.C.J. van de Donk; A. Broijl; S. Zweegman; M.D. Levin; M. Delforge; L. Pei; V. Vanquickelberghe; C. de Boer; T. Kampfenkel; J. Vermeulen; P. Sonneveld; IFM; HOVON 2020 |
|
|
Daratumumab plus bortezomib, thalidomide, and dexamethasone (D-VTd) in transplant-eligible newly diagnosed multiple myeloma (TE NDMM): Baseline SLiM-CRAB based subgroup analysis of CASSIOPEIA. C. Touzeau; P. Moreau; A. Perrot; C. Hulin; M. Dib; M. Tiab; D. Caillot; T. Facon; X. Leleu; N.W.C.J. van de Donk; A. Broijl; S. Zweegman; M.D. Levin; M. Delforge; L. Pei; V. Vanquickelberghe; C. de Boer; T. Kampfenkel; J. Vermeulen; P. Sonneveld; IFM; HOVON 2020 |